This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
n11http://dx.doi.org/10.1093/NDT/
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57218945
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunetu de 2011 наукова стаття, опублікована в лютому 2012 wetenschappelijk artikel article scientifique publié en 2011 scientific article published on 05 July 2011 im Juli 2011 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q57218945-387EACB7-6C47-4F4C-912A-BF2E23463DFD
wdt:P577
2011-07-05T00:00:00Z
p:P407
wds:Q57218945-3FA9E80E-EFE0-43D9-A10B-217E6FFCC532
wdt:P407
wd:Q1860
p:P2860
wds:Q57218945-335060E9-A5AF-45A4-B62E-2DC49EB82C8E wds:Q57218945-383BDB41-AF9D-4F48-B376-BB2EC209D950 wds:Q57218945-2A184672-74F3-463F-95C6-1C127E3FC001 wds:Q57218945-2FA33FF7-D746-46D6-B296-C82F0B96D573 wds:Q57218945-AAE0F9BD-C829-4212-B388-E52124AEF664 wds:Q57218945-AC8C862E-C45B-46D1-BD9B-855A851706E0 wds:Q57218945-AE67AA5C-F79A-462C-9BCA-59D36C80A636 wds:Q57218945-939B6591-0648-4EB8-A9AB-FAF0BC30E941 wds:Q57218945-9D381A60-8A3C-4590-95D3-CA401B014BAA wds:Q57218945-A3C35CBA-EBFE-4586-A4E6-6F784B345315 wds:Q57218945-825EA45E-9CE3-462C-903B-E9CF31A217C1 wds:Q57218945-88E9FF1A-EF48-4110-B3FD-643D68C96BE9 wds:Q57218945-8900A902-6272-4CE7-94D0-EAF3B8E80B30 wds:Q57218945-6E21CC46-3C84-4400-9880-5D6BAC6A12C6 wds:Q57218945-787FB90C-E187-4E14-87CC-C91A54BCE499 wds:Q57218945-8157D7A8-B0B8-4B6A-A768-65632285E977 wds:Q57218945-D6D93537-FA9D-4815-B10B-159478E07763 wds:Q57218945-E7486BD6-4F92-4AE0-96BC-0073B595E8AA wds:Q57218945-F63D0550-A8BB-4354-9BC9-8DEE66C95D0D wds:Q57218945-C76CB691-8A7D-490A-A894-4FBEC59BADF1 wds:Q57218945-C85F6453-C3EB-458D-8FE8-AE79955AB6E5 wds:Q57218945-D0312406-484B-46C1-A137-DC10DB7F8C53 wds:Q57218945-D501B541-EA9B-4725-8AEA-A95A4037360A wds:Q57218945-B6AC95B3-FE53-4EC8-A48F-A6216AB71C49 wds:Q57218945-B791DFE3-A771-4469-AD4D-FF5EFBDDF361 wds:Q57218945-BCD732D1-4873-4E8E-97D1-D8A7E2F32161 wds:Q57218945-C591D9B6-6385-4FF2-9E9B-CD40A7BFA046 wds:Q57218945-B21EE704-950C-46D5-89A7-B1B050E72B2E wds:Q57218945-B4FA5E6F-6A49-44E6-B5F5-FA331F267E50 wds:Q57218945-0C9C5E0B-FA90-4AED-BCFF-6D4D056F33CA wds:Q57218945-166FCB4B-827E-4773-8B5C-DDC2CD091CA2 wds:Q57218945-01F538ED-19CE-4D59-B9F9-658774CB2969 wds:Q57218945-5898830A-1315-413A-AA9F-EFC856B62C88 wds:Q57218945-3DC39ABE-7D65-46FE-9778-028B07578F4C wds:Q57218945-3F522940-9B82-4C99-AB42-FD91EDFFBFFA wds:Q57218945-318E40D7-E30F-4D39-8BCD-9DC7E3DF78BA
wdt:P2860
wd:Q46631801 wd:Q36947391 wd:Q46871114 wd:Q34557934 wd:Q54711237 wd:Q50735158 wd:Q34362759 wd:Q28213962 wd:Q40447584 wd:Q40447591 wd:Q37364439 wd:Q24319751 wd:Q37574346 wd:Q44835152 wd:Q46585085 wd:Q28572613 wd:Q46318788 wd:Q45197408 wd:Q46680438 wd:Q37654689 wd:Q44647160 wd:Q42493065 wd:Q46704863 wd:Q33878430 wd:Q37761243 wd:Q34017373 wd:Q33571321 wd:Q28583746 wd:Q33932297 wd:Q36982323 wd:Q33917786 wd:Q43016416 wd:Q33684149 wd:Q44985964 wd:Q52439505 wd:Q28575895
p:P2093
wds:Q57218945-B2C4E09D-2D52-47D1-B4BA-A813404352BE
wdt:P2093
Masahiro Koizumi
rdfs:label
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
skos:prefLabel
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
schema:name
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
p:P50
wds:Q57218945-5F086F14-43DD-4317-881A-961961793ADB wds:Q57218945-F713F91A-4129-484C-9DCD-83D09D247C2F wds:Q57218945-15A0768E-0C3E-4068-AFFD-25EA3AC02094 wds:Q57218945-8B1EEFDB-36FA-4D47-9D89-B3004C0E4544
wdt:P50
wd:Q37829361 wd:Q56997226 wd:Q114403280 wd:Q114403292
p:P1476
wds:Q57218945-5293D22E-FB1F-43CD-B315-AF024A28D024
wdt:P1476
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
p:P304
wds:Q57218945-31CE541F-81AC-4483-8002-CCD39145B84B
wdt:P304
784-790
p:P31
wds:Q57218945-F38DB70E-CA88-4A7B-9EBB-BA5CAF6C12C2
wdt:P31
wd:Q13442814
p:P921
wds:Q57218945-18323A47-0B2D-4291-A7EC-171FFF2AB15C wds:Q57218945-5E414EA7-700F-4E01-9219-199B5E00214F wds:Q57218945-A763ED31-8F02-439F-84CF-10546402A4D8
wdt:P921
wd:Q1344835 wd:Q3622611 wd:Q181600
p:P698
wds:Q57218945-7CA07CED-882A-481B-A91A-0715104437FE
wdtn:P698
n12:21730210
wdt:P698
21730210
p:P1433
wds:Q57218945-93BB547F-3C20-4452-84BC-AD13D2840166
wdt:P1433
wd:Q15710302
p:P433
wds:Q57218945-AFB509C4-B6D6-4735-B6C6-DA08E82AF758
p:P478
wds:Q57218945-0D4BFADA-35D1-416D-8521-0D59B7FF82F3
wdt:P433
2
wdt:P478
27
p:P356
wds:Q57218945-18127D89-FE30-4B79-BDD7-CA633359F819
wdtn:P356
n11:GFR384
wdt:P356
10.1093/NDT/GFR384